181 related articles for article (PubMed ID: 36069904)
1. Opportunistic Pathogens in Cystic Fibrosis: Epidemiology and Pathogenesis of Lung Infection.
Blanchard AC; Waters VJ
J Pediatric Infect Dis Soc; 2022 Sep; 11(Supplement_2):S3-S12. PubMed ID: 36069904
[TBL] [Abstract][Full Text] [Related]
2. The cystic fibrosis lung microbiome.
Surette MG
Ann Am Thorac Soc; 2014 Jan; 11 Suppl 1():S61-5. PubMed ID: 24437409
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology and management of pulmonary infections in cystic fibrosis.
Gibson RL; Burns JL; Ramsey BW
Am J Respir Crit Care Med; 2003 Oct; 168(8):918-51. PubMed ID: 14555458
[TBL] [Abstract][Full Text] [Related]
4. The microbiome and emerging pathogens in cystic fibrosis and non-cystic fibrosis bronchiectasis.
Green H; Jones AM
Semin Respir Crit Care Med; 2015 Apr; 36(2):225-35. PubMed ID: 25826590
[TBL] [Abstract][Full Text] [Related]
5. [Emerging bacteria in cystic fibrosis and non-cystic fibrosis bronchiectasis from a microbiologist's perspective].
Menetrey Q; Dupont C; Chiron R; Marchandin H
Rev Mal Respir; 2020 Sep; 37(7):561-571. PubMed ID: 32684338
[TBL] [Abstract][Full Text] [Related]
6. Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum.
Kolpen M; Kragh KN; Bjarnsholt T; Line L; Hansen CR; Dalbøge CS; Hansen N; Kühl M; Høiby N; Jensen PØ
Int J Med Microbiol; 2015 Jan; 305(1):1-10. PubMed ID: 25441256
[TBL] [Abstract][Full Text] [Related]
7. Investigation of Stenotrophomonas maltophilia epidemiology in a French cystic fibrosis center.
Capaldo C; Beauruelle C; Saliou P; Rault G; Ramel S; Héry-Arnaud G
Respir Med Res; 2020 Nov; 78():100757. PubMed ID: 32759054
[TBL] [Abstract][Full Text] [Related]
8. Pseudomonas aeruginosa Promotes Persistence of Stenotrophomonas maltophilia via Increased Adherence to Depolarized Respiratory Epithelium.
McDaniel MS; Lindgren NR; Billiot CE; Valladares KN; Sumpter NA; Swords WE
Microbiol Spectr; 2023 Feb; 11(1):e0384622. PubMed ID: 36472421
[TBL] [Abstract][Full Text] [Related]
9. Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis-data from the European cystic fibrosis society patient registry.
Hatziagorou E; Orenti A; Drevinek P; Kashirskaya N; Mei-Zahav M; De Boeck K; ;
J Cyst Fibros; 2020 May; 19(3):376-383. PubMed ID: 31492646
[TBL] [Abstract][Full Text] [Related]
10. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis.
Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
BMC Infect Dis; 2017 Jun; 17(1):411. PubMed ID: 28599639
[TBL] [Abstract][Full Text] [Related]
11. Challenging and emerging pathogens in cystic fibrosis.
de Vrankrijker AM; Wolfs TF; van der Ent CK
Paediatr Respir Rev; 2010 Dec; 11(4):246-54. PubMed ID: 21109184
[TBL] [Abstract][Full Text] [Related]
12.
Menetrey Q; Sorlin P; Jumas-Bilak E; Chiron R; Dupont C; Marchandin H
Genes (Basel); 2021 Apr; 12(5):. PubMed ID: 33919046
[TBL] [Abstract][Full Text] [Related]
13. Respiratory bacterial infections in cystic fibrosis.
Ciofu O; Hansen CR; Høiby N
Curr Opin Pulm Med; 2013 May; 19(3):251-8. PubMed ID: 23449384
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary infections in patients with cystic fibrosis.
Rajan S; Saiman L
Semin Respir Infect; 2002 Mar; 17(1):47-56. PubMed ID: 11891518
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections.
Heirali A; McKeon S; Purighalla S; Storey DG; Rossi L; Costilhes G; Drews SJ; Rabin HR; Surette MG; Parkins MD
PLoS One; 2016; 11(2):e0148534. PubMed ID: 26859493
[TBL] [Abstract][Full Text] [Related]
16. Cooperativity between Stenotrophomonas maltophilia and Pseudomonas aeruginosa during Polymicrobial Airway Infections.
McDaniel MS; Schoeb T; Swords WE
Infect Immun; 2020 Mar; 88(4):. PubMed ID: 31932329
[No Abstract] [Full Text] [Related]
17. Air pollution exposure is associated with MRSA acquisition in young U.S. children with cystic fibrosis.
Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
BMC Pulm Med; 2017 Jul; 17(1):106. PubMed ID: 28750627
[TBL] [Abstract][Full Text] [Related]
18. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis.
Krzewinski JW; Nguyen CD; Foster JM; Burns JL
J Clin Microbiol; 2001 Oct; 39(10):3597-602. PubMed ID: 11574579
[TBL] [Abstract][Full Text] [Related]
19. New treatments for emerging cystic fibrosis pathogens other than Pseudomonas.
Waters V
Curr Pharm Des; 2012; 18(5):696-725. PubMed ID: 22229574
[TBL] [Abstract][Full Text] [Related]
20. Infection control recommendations for patients with cystic fibrosis: Microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission.
Saiman L; Siegel J;
Am J Infect Control; 2003 May; 31(3 Suppl):S1-62. PubMed ID: 12762292
[No Abstract] [Full Text] [Related]
[Next] [New Search]